Shoulder Innovations

Shoulder Innovations Capital Expenditures

The Capital Expenditures (CapEx) of Shoulder Innovations (SI) as of Oct 20, 2026 is -7.41 M USD. In the previous year, Capital Expenditures (CapEx) was -4.02 M USD — a change of 84.51% (lower).

Capital Expenditures

-7.41 MUSD

YoY

84.51%

Last updated:

Capital Expenditures (CapEx) of Shoulder Innovations is 2025 -7.41 M USD. Capital Expenditures (CapEx) of Shoulder Innovations was 2024 -4.02 M USD. It decreases by 84.51% lower compared to the previous year.

The Shoulder Innovations Capital Expenditures history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Expenditures
Date
Capital Expenditures
Jan 1, 2018
-2.66 M USD
Jan 1, 2019
-1.21 M USD
Jan 1, 2020
-920,000.00 USD
Jan 1, 2021
-1.92 M USD
Jan 1, 2022
-2.35 M USD
Jan 1, 2023
-2.75 M USD
Jan 1, 2024
-4.02 M USD
Jan 1, 2025
-7.41 M USD
The Shoulder Innovations Capital Expenditures history
YEARCapital ExpendituresYoY
-7.41 MUSD+84.51%
-4.02 MUSD+46.11%
-2.75 MUSD+16.74%
-2.35 MUSD+22.60%
-1.92 MUSD+108.70%
-920,000.00USD-23.97%
-1.21 MUSD-54.51%
-2.66 MUSD+137.50%
-1.12 MUSD+89.83%
-590,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shoulder Innovations Stock analysis

What does Shoulder Innovations do? Shoulder Innovations Inc generates revenue through its advanced implant systems for shoulder arthroplasty, specifically the aTSA and rTSA systems, which address patient and surgeon needs with customizable configurations for anatomic or reverse procedures. The company's ecosystem includes enabling technologies, instrument systems, specialized support, and surgeon-to-surgeon collaboration, enhancing preoperative planning, implant design, and procedural efficiency across the care chain. Its InSet Glenoid technology forms the foundational element of these systems, supporting comprehensive surgical solutions for healthcare providers. The firm targets hospitals and surgical centers as primary buyers, leveraging its commercial-stage medical technology focus to serve the shoulder surgical care market. The company's product portfolio centers on aTSA and rTSA systems, designed to improve core components of shoulder surgical care, with InSet Glenoid as the cornerstone of its implant solutions. These systems are sold to healthcare institutions seeking advanced surgical tools that streamline procedures and improve patient outcomes. Shoulder Innovations Inc capitalizes on its ecosystem approach, bundling implant systems with enabling technologies and support services to create a cohesive offering for medical professionals. The firm’s commercial-stage position allows it to directly engage with hospitals and surgical centers as key customers in the healthcare equipment and supplies sector. Shoulder Innovations Inc's revenue model relies on selling its advanced implant systems, including aTSA and rTSA, alongside InSet Glenoid technology, to hospitals and surgical centers. The company emphasizes procedural efficiency and preoperative planning through its ecosystem, which includes instrument systems and surgeon collaboration tools. By focusing on shoulder arthroplasty, the firm targets a specialized segment within the healthcare market, offering tailored solutions that address both patient requirements and surgical workflow optimization. The company’s products are designed to integrate seamlessly into existing surgical practices, enhancing care delivery across the shoulder surgical care chain. Shoulder Innovations is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shoulder Innovations stock

Capital Expenditures (CapEx) of Shoulder Innovations is -7.41 M USD in 2025.

Capital Expenditures (CapEx) of Shoulder Innovations changed from -4.02 M USD to -7.41 M USD, representing a 84.51% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Capital Expenditures (CapEx) Shoulder Innovations since 2006 – with annual values, charts, and detailed analysis.

Capital expenditures represent investments in long-term assets such as property, equipment, and technology. CapEx is essential for maintaining and growing the business.

Capital Expenditures (CapEx)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Capital Expenditures (CapEx)'s Shoulder Innovations historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Shoulder Innovations

All Key Metrics — Shoulder Innovations